1. Volume 381, Issue 9872, Pages 1107-1115 (March 2013)
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial 
Dr Willem JM Dewilde, MD, Tom Oirbans, MSc, Prof Freek WA Verheugt, MD, Johannes C Kelder, MD, Bart JGL De Smet, MD, Jean- Paul Herrman, MD, Tom Adriaenssens, MD, Mathias Vrolix, MD, Antonius ACM Heestermans, MD, Marije M Vis, MD, Prof Jan GP Tijsen, MD, Arnoud W van 't Hof, MD, Jurriën M ten Berg, MD 
The Lancet 
Volume 381, Issue 9872, Pages (March 2013)
DOI: /S (12)
Copyright © 2013 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
PCI=percutaneous coronary intervention. *Two patients in the double-therapy group and one in the triple-therapy group were included in the intention-to-treat analysis until the day of withdrawal.
The Lancet  , DOI: ( /S (12) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

3. Figure 2 Incidence of the primary endpoint (any bleeding)
HR=hazard ratio.
The Lancet  , DOI: ( /S (12) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

4. Figure 3
Cumulative incidence of the secondary endpoint (death, myocardial infarction, stroke, target-vessel revascularisation, and stent thrombosis)
HR=hazard ratio.
The Lancet  , DOI: ( /S (12) )
Copyright © 2013 Elsevier Ltd Terms and Conditions